logo
#

Latest news with #Ivermectin

Scientists are studying ways to make your blood deadly to mosquitos
Scientists are studying ways to make your blood deadly to mosquitos

Vancouver Sun

time7 hours ago

  • Health
  • Vancouver Sun

Scientists are studying ways to make your blood deadly to mosquitos

A new study in the New England Journal of Medicine has found that ivermectin, an antiparasitic drug used to treat tropical diseases such as river blindness, can also fight the spread of malaria. It does so in a way that seems oddly (and satisfyingly) like revenge against the mosquitos that carry the disease. It makes the user's blood a deadly poison to the insects that want to consume it. The new study, Ivermectin to Control Malaria — A Cluster-Randomized Trial , published this month, found that malaria cases dropped by 26 per cent in those who took the medication monthly. Researchers also noted a drop in cases of lice, scabies and bedbugs among participants in the trial. Start your day with a roundup of B.C.-focused news and opinion. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Sunrise will soon be in your inbox. Please try again Interested in more newsletters? Browse here. The study, led by the Barcelona Institute for Global Health , took place in Kwale, a county in coastal Kenya that has a high rate of malaria in spite of such techniques as the use of insecticide-treated nets. Clusters of household areas were assigned to receive mass administration of ivermectin for three months beginning at the start of the rainy season. Children aged 5 to 15 were then tested for malaria infection monthly for 6 months after the first round of treatment. 'Among children 5 to 15 years of age who were living in an area with high coverage and use of bed nets, ivermectin, administered once a month for three consecutive months, resulted in a 26 per cent lower incidence of malaria infection than albendazole (the control drug),' the researchers wrote. They added: 'No safety concerns were identified.' The researchers note that there were 249 million cases of malaria and 608,000 malaria-related deaths in 2022 alone. 'Interventions targeting the vector, such as long-lasting insecticide-treated nets or indoor residual spraying, remain the cornerstone of malaria control and are responsible for the estimated 81 per cent reduction in disease burden seen in Africa between 2000 and 2015,' they note. ('Vector' refers to an insect such as a mosquito that transmits a disease such as malaria.) 'However, progress has stalled in recent years (due to) emerging resistance to insecticides and behavioural adaptations, such as outdoor and crepuscular biting.' Ivermectin isn't the only drug being tested as a way to kill mosquitoes with the very thing they feed on. Another recent study investigated the effects of nitisinone, a drug used to treat rare metabolic disorders. 'The authors show that nitisinone targeted a crucial enzyme that mosquitoes need to digest their blood meal,' those researchers write. 'When female Anopheles mosquitoes in the laboratory consumed blood containing nitisinone, the drug was lethal to young, old, and insecticide-resistant populations and outperformed the mosquitocidal drug ivermectin. Even at low therapeutic doses, nitisinone remained deadly to mosquitoes. These findings warrant further investigation of nitisinone for vector control and the prevention of malaria transmission.' Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our newsletters here .

State to administer anti-filariasis drugs to 1.27cr residents from Aug 10
State to administer anti-filariasis drugs to 1.27cr residents from Aug 10

Time of India

time5 days ago

  • Health
  • Time of India

State to administer anti-filariasis drugs to 1.27cr residents from Aug 10

Ranchi: To eliminate lymphatic filariasis from state, the department of health, medical education and family welfare will roll out the second round of Mass Drug Administration (MDA) from August 10, targeting over 1.27 crore people across 80 identified blocks in nine districts. The round of MDA will include the administration of three medicines — DEC, Albendazole, and Ivermectin. Additional chief secretary of health department, Ajoy Kumar Singh said, "Anti-filariasis medicines are not just distributed but consumed in the presence of trained health workers to ensure efficacy. Make people aware about the importance of anti-filariasis medicines to stay safe from the disease." Singh appealed to departments such as Education, ICDS, Panchayati Raj, Urban Development, PHED, and Livelihood to cooperate actively in the MDA campaign. State programme officer Dr Birendra Kumar Singh said, "Every eligible individual will be reached. The MDA hinges on detailed micro-planning, community awareness, and strong monitoring. Review meetings will be held daily at district and block levels, with a state-level assessment during the campaign to ensure proper implementation. If the community consistently takes the prescribed anti-filarial medicines annually for five years, the disease can be eliminated from the state. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top 15 Most Beautiful Women in the World Undo " Moreover, the state is also proactively implementing the STOP Diarrhoea Campaign, running from July 1 to August 14, aiming to prevent child deaths due to diarrhoea. Experts said with diarrhoea contributing to 4.1% of child mortality under the age of five in India, the state is taking comprehensive measures under the campaign.

GP must pay $65k for prescribing Ivermectin
GP must pay $65k for prescribing Ivermectin

Otago Daily Times

time04-07-2025

  • Health
  • Otago Daily Times

GP must pay $65k for prescribing Ivermectin

A Southland doctor has been forced to pay more than $65,000 after she admitted importing and administering Ivermectin during the height of the Covid pandemic. Dr Sophie Jane Febery, registered medical practitioner of Mataura, whose suppression order has lapsed, has had previous charges of misconduct upheld by the New Zealand Health Practitioners Disciplinary Tribunal. The tribunal decision was released to the public yesterday. The decision said it was believed the incidents occurred in 2021, and the tribunal noted Dr Febery was not alone in her behaviour. Similar cases had involved nurses who actively and extensively sought to influence members of the public, including by directly encouraging them not to get vaccinated or to undermine the roll-out of the vaccine. While Dr Febery's actions were less serious than that, the tribunal found they were incredibly risky to people's health and wellbeing. "It spanned several months, and involved prescribing for 29 patients and inadequate record-keeping for 26 patients as well as the attempted importation of 2000 Ivermectin tablets and authorisation of release of Ivermectin to three individuals, contrary to the requirements of the Medicines Act. "In that sense, her wrongdoing was extensive." The tribunal was particularly critical about her inaccurate record-keeping. "Adequate and accurate record-keeping is an important part of ensuring continuity of care. "Dr Febery said that she was not concerned about the continuity of care because it did not seem like a medical issue. The reason the patients had consulted her was for a vaccine exemption letter. "She said that they had online access to prescriptions, but acknowledged it would have made it difficult for the GPs to provide continuity of care." Dr Febery agreed to part of the charge and, eventually, consented to the destruction of the imported Ivermectin when testing showed she had imported substandard medicine. Dr Febery also attended a "freedom rights" rally in Christchurch in October 2021, which was held in response to the Covid-19 vaccination mandate and was attended by members of the public — she introduced herself as a "rural GP from Methven" and, having identified herself as a doctor, she gave a speech. She said she had "started researching like mad" when the Pfizer vaccine was introduced and that 'top scientists' had changed her mind about receiving a vaccine, and that 'the pandemic is not as deadly as we thought it was last year'. The New Zealand Medical Council said it was irresponsible, and unacceptable, for a practising GP to have made such a comment in the midst of a global pandemic. To do so was a breach of her professional obligations not to allow her personal beliefs to affect her advice, and there could be an issue of public safety. Regarding her importing of Ivermectin, the tribunal said: "This was not a case of one slip or inadvertent error". "The tribunal finds that Dr Febery's unlawful conduct amounts to malpractice and negligence and is sufficiently serious to warrant a disciplinary sanction." It also remarked that her public comments about the Covid-19 vaccine suggested a lack of research rigour. "Her research and critical appraisal skills were explored briefly by the tribunal during her evidence. In that area the practitioner did not demonstrate insight. "It was evident that her inquiry into the Pfizer vaccine was the most research she had ever undertaken into a new procedure, medication or vaccine." The tribunal ordered her to take and successfully complete an educational programme approved by the Medical Council about critical appraisal skills so research could be analysed appropriately. She was formally censured and also ordered to pay a total of $67,196.52, comprising $39,874.50 contribution towards the professional conduct committee costs and $27,322.02 for the tribunal's costs. For three years, Dr Febery will be required to advise any workplace of the tribunal's decisions.

What Louisiana lawmakers passed in 2025
What Louisiana lawmakers passed in 2025

Axios

time13-06-2025

  • Politics
  • Axios

What Louisiana lawmakers passed in 2025

Louisiana lawmakers wrapped up their legislative session on Thursday, putting a bow on 60 days of deal making and budgeting. Why it matters: Gov. Jeff Landry has already pulled out his pen to start signing new legislation, making official more than 100 new laws by Friday. The big picture: Because this year's session was all about the state's financials, lawmakers had limited ability to focus on other priorities. But limited does not mean none, so there are still changes to state laws that you should know about. Here's a look at some of this session's most notable edits: 💰 Budget passes: The state got a $51 billion budget for the fiscal year that starts in July. Notable line items include: $1.8 million for the manhunt stemming from the New Orleans jail escape, according to the AP. $1.2 billion in one-time funds from a state savings account to pay for infrastructure improvements, plus site prep for future economic development pitches. No additional funding for Landry's LA GATOR school voucher program, according to the Louisiana Illuminator. Teachers and support staff will get some pay increases through HB 466, which the state will pay for with education trust funds. 🚙 Car insurance changes: Heading into this session, Landry eyed changes that he believes could help lower car insurance rates for Louisiana citizens. Landry signed legislation to give the state insurance commissioner more authority to reject rate increases, offer discounts for dashcams for some trucking companies, prevent undocumented immigrants from collecting damages in car accidents and other changes. 🍎 MAHA trends: Some lawmakers prioritized legislation inspired by HHS Sec. Robert F. Kennedy Jr's. "Make America Healthy Again" policies. Sen. Patrick McMath's bill that bans some artificial food dyes and additives from school foods got the OK. Restaurants would also have to post if they use seed oils. With Landry's signature, it would take effect in 2028. Lawmakers also approved a now-signed bill to ban " chemtrails," a conspiracy theory-based idea that chemicals are released from the vapor threads seen behind airplanes. Ivermectin, which some MAHA influencers say can help cure coronavirus despite studies showing it is ineffective, would become accessible in over-the-counter purchases, with Landry's signature. Another MAHA-adjacent bill to ban fluoride in the state's water did not pass. 🤳 Talking while driving: With Landry's signature, it'll soon be illegal to hold a cell phone while driving. Law enforcement are instructed to issue warnings until Jan. 1, 2026, after which drivers would face fines. 🎓 UNO merges into LSU system: Facing ongoing financial struggles, the New Orleans university will now be part of the flagship university's system. Go deeper from The Times-Picayune. Other school updates include a new TOPS award for students who score at least a 31 on the ACT and a two-hour course requirement on hazing for students who participate in student organizations. It was inspired by Southern University student Caleb Wilson's death earlier this year. 💨 Kratom ban: The herbal substance, which critics say has abuse potential, will be banned, with Landry's signature. 🎈 Balloon releases banned: The rest of the state caught up with New Orleans' ban on balloon releases after ongoing power outage issues, according to Louisiana First News. 💊 What we're watching: Landry has threatened to call a special session to address prescription drug costs. A controversial bill was scuttled in the 11th hour on Thursday after a fierce battle between some of the largest pharmacy benefits managers, like CVS, and Landry and his supporters, who sought to ban companies from owning PBMs and pharmacies. The bill, however, would not take effect until 2027, so Sen. Cameron Henry told The Times-Picayune he doesn't see the point in holding a special session for an issue that could be taken up next year instead.

Lawmakers decide which bills worth negotiating and kill the rest
Lawmakers decide which bills worth negotiating and kill the rest

Yahoo

time12-06-2025

  • Health
  • Yahoo

Lawmakers decide which bills worth negotiating and kill the rest

On a day when the House and Senate created negotiating committees to try and salvage 50 bills, they voted to summarily kill about 15 others after concluding that compromise was unlikely to be reached on them. A major reform bill (SB 297) that hit the cutting room floor Thursday was the pitched battle between Secretary of State David Scanlan and HealthTrust, the state's largest risk pool, over whether Scanlan should get enhanced power to regulate these groups that manage insurance plans for units of government. Last week, the House of Representatives rejected Scanlan's reforms in favor of an amendment that would have let the groups decide whether to come under the regulation of Scanlan's office or the Insurance Department. Without debate, Senate Commerce Committee Chairman Dan Innis, R-Bradford, asked the Senate to 'non-concur' on the House changes and the Senate did on a voice vote which killed the measure. Scanlan said killing the bill made sense. "I am pleased the Senate voted to non-concur on the House amended version of SB 297. What began as an attempt to improve the transparency and accountability of pooled risk organizations entrusted with $750 million taxpayer dollars became an attempt by one risk pool to move to a regulatory environment favorable to them without addressing the underlying concerns," Scanlan said in a statement. Ivermectin bill rejected The Senate also decided to reject out of hand a controversial House-passed proposal (SB 119) to allow any doctor or pharmacist to provide ivermectin to any patient without a prescription. Ivermectin was created as a drug to treat parasites for animals but in the past decade it proved to be a prize-winning medication to treat humans for similar conditions. During COVID-19, the drug became a viral sensation for many Americans who used it to respond to the virus. House Democratic Floor Leader Lucy Weber of Walpole had argued against giving ivermectin the special status of having a 'standing order' for any patient. She noted the only medications that have that designation are EpiPens that treat allergic reactions, smoking prevention drugs and some forms of contraception. This was the main reason that former Gov. Chris Sununu gave when he vetoed a similar bill to this one. Rep. Yuri Polozov, R-Hooksett, said he pursued the bill because during the pandemic many medical providers were ostracized or even sanctioned for prescribing ivermectin. Many other bills were also killed because sections that legislators still wanted to survive had been tacked onto another bill. In this case, the original bill the House amended to favor ivermectin was expected to save the state up to $9 million a year to allow health care providers to prescribe brand name drugs in the Medicaid program if they have discounts or rebates that make these medications cheaper to purchase. The state Senate tacked that provision onto the trailer bill of its state budget. In a similar vein, the Senate on Thursday killed a bill (SB 60) dealing with legalized gambling that would have taken from state regulators and given to the Legislature the authority to write rules regarding immunization requirements. The House had already tacked that section onto the version of its own budget trailer bill. Another bill (SB 100) that died Thursday was meant to alter a 2021 ban on teaching discrimination in public schools to respond to a federal judge's ruling that struck it down as unconstitutionally too vague. The House-passed language would require a showing that the educator 'knowingly' was advocating bias in his or her teachings. Some socially conservative groups that supported the law had warned lawmakers that the House bill only addressed a small part of the legal flaws with the existing law. The Senate also rejected a House-passed bill that would have created a court docket to resolve disputes over so-called blockchain currencies such as bitcoin (SB 25). klandrigan@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store